Sangamo Therapeutics Inc. buy Wells Fargo & Company
Start price
10.08.23
/
50%
€0.99
Target price
10.08.24
€3.63
Performance (%)
-6.87%
End price
11.08.24
€0.92
Summary
This prediction ended on 11.08.24 with a price of €0.92. With a performance of -6.87%, the BUY prediction by Wells_Fargo___Compan finished with a loss. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -30.351% | -30.351% | -70.002% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Wells Fargo & Company from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Wells_Fargo___Compan gewählte maximale Laufzeit wurde überschritten